Re: Screening and prostate cancer mortality: Results of the European randomised study of screening for prostate cancer (ERSPC) at 13 years of follow-up

摘要

The European Randomised Study of Screening for Prostate Cancer (ERSPC) is a multicentre, randomised trial comparing men who were exposed to prostate-specific antigen (PSA) screening with men who were not. The primary end point is mortality from prostate cancer (PCa). From 1993,162 388 men aged 50-74 yr were recruited into the trial, and an updated analysis of the results at 13 yr from randomisation has now been published.